BARTOLINI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 16.302
NA - Nord America 9.469
AS - Asia 1.484
AF - Africa 71
SA - Sud America 21
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 27.351
Nazione #
PL - Polonia 11.344
US - Stati Uniti d'America 9.440
RU - Federazione Russa 1.615
SE - Svezia 730
IE - Irlanda 665
IT - Italia 556
UA - Ucraina 494
SG - Singapore 331
HK - Hong Kong 329
DE - Germania 327
VN - Vietnam 241
GB - Regno Unito 238
CN - Cina 236
FI - Finlandia 208
IN - India 107
KR - Corea 93
TR - Turchia 65
FR - Francia 40
JO - Giordania 40
CI - Costa d'Avorio 37
SC - Seychelles 33
CA - Canada 26
JP - Giappone 22
CH - Svizzera 21
BE - Belgio 20
NL - Olanda 16
BR - Brasile 13
RO - Romania 6
PE - Perù 5
HR - Croazia 4
LV - Lettonia 4
TW - Taiwan 4
ES - Italia 3
IR - Iran 3
AM - Armenia 2
AR - Argentina 2
AT - Austria 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
IL - Israele 2
MX - Messico 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BO - Bolivia 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 27.351
Città #
Warsaw 11.341
Santa Clara 1.340
Fairfield 1.091
Ashburn 817
Jacksonville 743
Dublin 665
Chandler 607
Woodbridge 505
Seattle 470
Cambridge 456
Wilmington 407
Houston 376
Dong Ket 223
Singapore 223
Hong Kong 200
Altamura 170
Ann Arbor 165
Princeton 165
Boardman 143
Lawrence 137
Boston 111
Beijing 102
Mumbai 99
San Diego 84
Seongnam 73
Medford 71
Phoenix 69
Izmir 61
Shanghai 56
Falls Church 55
Milan 53
Buffalo 45
Washington 40
Abidjan 37
Helsinki 35
Florence 32
Moscow 31
Los Angeles 27
Frankfurt Am Main 26
Kent 26
Norwalk 26
Auburn Hills 25
Hillsboro 24
West Jordan 24
New York 21
Bern 20
Brussels 20
Verona 19
Andover 18
Dearborn 18
Guangzhou 18
Tokyo 15
London 14
Yubileyny 14
Toronto 13
Philadelphia 11
Tappahannock 9
Mcallen 8
Ottawa 8
Saint Louis 8
Seoul 8
Bremen 7
Las Vegas 6
Redwood City 6
Lappeenranta 5
Lima 5
Moncalieri 5
Munich 5
Redmond 5
San Jose 5
Amsterdam 4
Easton 4
Frankfurt am Main 4
Fuzhou 4
Kilburn 4
Palermo 4
Riga 4
Sesto Fiorentino 4
Acton 3
Bucharest 3
Central 3
Chicago 3
Dallas 3
Fano 3
Genoa 3
Monza 3
Pune 3
Romola 3
Salerno 3
San Martino Buon Albergo 3
Sassano 3
Turate 3
Atlanta 2
Bengaluru 2
Berlin 2
Bitonto 2
Buccinasco 2
Buenos Aires 2
Casnate Con Bernate 2
Catania 2
Totale 21.857
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 458
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 363
M1 receptor activation is a requirement for arecoline analgesia. 352
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 302
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 294
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 293
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 287
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 283
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 277
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 269
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 268
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 264
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 263
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 263
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 262
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 261
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 259
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 258
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 257
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 257
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 256
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 256
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 255
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 254
Prochlorperazine induces central antinociception mediated by the muscarinic system. 251
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 250
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 250
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 250
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 249
Role of intracellular calcium in acute thermal pain perception 249
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 248
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 247
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 247
Memory facilitation with atropine: a paradoxical effect 246
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 246
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 245
Effect of K+ channel modulation on mouse feeding behaviour 245
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 245
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 245
Influence of potassium channel modulators on cognitive processes in mice 244
Endogenous morphine modulates acute thermonociception in mice. 244
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 243
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 242
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 242
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 242
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 241
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 240
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 239
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 238
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 237
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 237
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 236
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 235
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 235
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 235
In vitro characterization of a novel, potent and selective M3 antagonist 234
Ryanodine receptors are involved in muscarinic antinociception in mice. 234
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 234
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 231
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 230
Local anaesthetic activity of beta-caryophyllene. 227
Caffeine induces central cholinergic analgesia. 225
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 225
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 224
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 223
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 223
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 223
Neuropathy-induced apoptosis: Protective effect of physostigmine 222
ANTINOCICEPTION INDUCED BY SM32 DEPENDS ON CENTRAL CHOLINERGIC MECHANISM 221
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 221
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. 220
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 219
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channe 218
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 217
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat 210
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. 210
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 208
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 207
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 207
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the ACh releaser PG9 206
PHARMACOLOGICAL IDENTIFICATION OF SM-21, THE NOVEL SIGMA2 ANTAGONIST 204
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 199
Antagonism by piracetam of baclofen antinociception 198
Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors 197
ANTINOCICEPTION INDUCED BY AMITRIPTYLINE AND IMIPRAMINE IS MEDIATED BY A2A-ADRENOCEPTORS 194
Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits. 187
Structure-affinity relationships of a unique nicotinic ligand: N1-dimethyl-N4-phenylpiperazinium iodide (DMPP) 132
Chiral synthesis and pharmacological evaluation of the enantiomers of SM32, a new analgesic and cognition-enhancing agent. 132
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 128
Gi/o proteins: expression for direct activation enquiry 127
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression 125
INVESTIGATION INTO THE ROLE OF HISTAMINE RECEPTORS IN RODENT ANTINOCICEPTION 122
PRESYNAPTIC AUTO- AND HETERO-RECEPTORS IN THE CHOLINERGIC REGULATION OF PAIN 121
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 1. Tropic and 2-Phenylpropionic Acid Esters 120
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 120
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram). 119
ROLE OF MUSCARINIC RECEPTOR SUBTYPES IN CENTRAL ANTINOCICEPTION 119
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 119
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 117
Role of histamine in rodent antinociception 115
Totale 22.768
Categoria #
all - tutte 56.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.517 0 0 0 0 606 533 412 673 387 306 552 48
2020/20213.911 314 407 181 489 205 474 206 337 277 550 82 389
2021/20221.296 29 155 106 36 65 74 55 75 77 86 247 291
2022/20232.779 261 464 135 206 241 505 383 158 257 13 102 54
2023/20241.453 57 132 219 72 81 228 48 449 29 49 45 44
2024/20253.973 241 684 416 892 1.740 0 0 0 0 0 0 0
Totale 27.496